<!DOCTYPE html>
<html><head><style>table, th, td {border: 1px solid black;border-collapse: collapse;}</style></head>
<table colsep="0" frame="topbot" id="tbl1" trsep="0" xmlns="http://www.elsevier.com/xml/common/cals/dtd">
<label>
        Table 1
       </label>
<caption id="cap0045">
<simple-para id="tspara0010" view="all">
         Supporting Evidence for Selected lncRNAs
        </simple-para>
</caption>
<tgroup cols="3">
<colspec colname="col1" colnum="1"/>
<colspec colname="col2" colnum="2"/>
<colspec colname="col3" colnum="3"/>
<thead>
<tr trsep="1" valign="bottom">
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           lncRNA
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           Association
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           References
          </td>
</tr>
</thead>
<tbody>
<tr valign="top">
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<italic>
            CASC9
           </italic>
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           increased expression associated with poor survival and metastasis in ESCC
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">

<sup loc="post">
            ,
           </sup>

</td>
</tr>
<tr valign="top">
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<italic>
            PART1
           </italic>
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           increased expression in serum exosomes associated with gefitinib resistance in ESCC
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">

</td>
</tr>
<tr valign="top">
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<italic>
            CCAT1
           </italic>
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           increased expression associated with TNM stage and poor survival in ESCC
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">

</td>
</tr>
<tr valign="top">
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<italic>
            TTN-AS1
           </italic>
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           promotes ESCC cell proliferation and metastasis
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">

</td>
</tr>
<tr valign="top">
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<italic>
            TUG1
           </italic>
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           promotes cisplatin resistance in ESCC cells
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">

</td>
</tr>
<tr valign="top">
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<italic>
            AFAP1-AS1
           </italic>
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           increased expression associated with cisplatin resistance and poor survival in ESCC
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">

</td>
</tr>
<tr valign="top">
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<italic>
            DNM3OS
           </italic>
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           increased expression associated with tumor progression in ESCC
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">

</td>
</tr>
<tr valign="top">
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<italic>
            FMR1-AS1
           </italic>
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           could be packaged into exosomes and released into the TME of ESCC
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">

</td>
</tr>
<tr valign="top">
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<italic>
            HNF1A-AS1
           </italic>
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           promotes cancer cells proliferation and migration in esophageal cancer
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">

</td>
</tr>
<tr valign="top">
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<italic>
            LINC01419
           </italic>
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           diminish the sensitivity of ESCC to 5-FU
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">

</td>
</tr>
<tr valign="top">
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<italic>
            NMR
           </italic>
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           inhibit cisplatin-induced apoptosis and increase drug resistance in ESCC
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">

</td>
</tr>
<tr valign="top">
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<italic>
            PCAT1
           </italic>
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           promotes ESCC cells proliferation through exosomes
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">

</td>
</tr>
<tr valign="top">
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<italic>
            POU3F3
           </italic>
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           promotes cell viability and proliferation in ESCC cells; could be released into serum of ESCC
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">

<sup loc="post">
            ,
           </sup>

</td>
</tr>
<tr valign="top">
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<italic>
            ROR
           </italic>
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           promotes cancer cell proliferation and cisplatin resistance
           <italic>
            inÂ vitro
           </italic>
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">

</td>
</tr>
</tbody>
</tgroup>
<legend>
<simple-para id="tspara0015" view="all">
         TNM, tumor, node, metastasis; 5-FU, 5-fluorouracil.
        </simple-para>
</legend>
</table>
</html>
